Search research articles
Contact Us
Filters
Showing results (391-400 of 440) with videos related to
Page
of 44
Sort By:
Blood
|
June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
Shaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
The Journal of Clinical Investigation
|
August 1, 2023
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
M Hope Robinson, Nancy Y Villa, David L Jaye, et al.
The Lancet. Oncology
|
April 4, 2017
Role of <sup>18</sup>F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Michele Cavo, Evangelos Terpos, Cristina Nanni, et al.
Molecular Cell
|
November 22, 2016
Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth
Jun Fan, Ruiting Lin, Siyuan Xia, et al.
Cell Metabolism
|
January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Siyuan Xia, Ruiting Lin, Lingtao Jin, et al.
Blood Cancer Discovery
|
December 13, 2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, et al.
JCO Oncology Practice
|
May 30, 2020
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States
Yang Yu, Niquelle Brown Wade, Amie E Hwang, et al.
The New England Journal of Medicine
|
August 30, 2023
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma
Paul G Richardson, Suzanne Trudel, Rakesh Popat, et al.
Lancet (London, England)
|
January 19, 2016
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
Sagar Lonial, Brendan M Weiss, Saad Z Usmani, et al.
Page
of 44
Search research articles
Search
Showing results (391-400 of 440) with videos related to
Sort By:
Page
of 44
Blood
|
June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
Shaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
The Journal of Clinical Investigation
|
August 1, 2023
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
M Hope Robinson, Nancy Y Villa, David L Jaye, et al.
The Lancet. Oncology
|
April 4, 2017
Role of <sup>18</sup>F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Michele Cavo, Evangelos Terpos, Cristina Nanni, et al.
Molecular Cell
|
November 22, 2016
Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth
Jun Fan, Ruiting Lin, Siyuan Xia, et al.
Cell Metabolism
|
January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Siyuan Xia, Ruiting Lin, Lingtao Jin, et al.
Blood Cancer Discovery
|
December 13, 2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, et al.
JCO Oncology Practice
|
May 30, 2020
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States
Yang Yu, Niquelle Brown Wade, Amie E Hwang, et al.
The New England Journal of Medicine
|
August 30, 2023
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma
Paul G Richardson, Suzanne Trudel, Rakesh Popat, et al.
Lancet (London, England)
|
January 19, 2016
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
Sagar Lonial, Brendan M Weiss, Saad Z Usmani, et al.
Page
of 44